Xiang Ma
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Molecular Medicine top 5%
- Curcumin's Biomedical Applications
Papers in
-
- RNA Interference and Gene Delivery 7
- Oncology 18
- Peptidase Inhibition and Analysis 6
- Drug Transport and Resistance Mechanisms 6
- Co-authors
- Guangya Xiang (35 shared papers)Tan Yang (10 shared papers)Chuanchuan He (12 shared papers)Pengxuan Zhao (10 shared papers)Wai‐Keung Chui (7 shared papers)Yongkang Gai (14 shared papers)Yao Lu (9 shared papers)Wendian Zhang (4 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (6 papers)Bioconjugate Chemistry (4 papers)International Journal of Pharmaceutics (4 papers)International Journal of Nanomedicine (4 papers)Acta Pharmaceutica Sinica B (2 papers)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Xiang Ma
59 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 106
- Biomaterials 447
- Molecular Medicine 101
- Cancer Research 187
- Pharmaceutical Science 74
- Organic Chemistry 292
Countries citing papers authored by Xiang Ma
This map shows the geographic impact of Xiang Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiang Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiang Ma more than expected).
Fields of papers citing papers by Xiang Ma
This network shows the impact of papers produced by Xiang Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiang Ma. The network helps show where Xiang Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiang Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 60 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 133 | |
| 2 | 2019 | 81 | |
| 3 | 2020 | 78 | |
| 4 | 2015 | 72 | |
| 5 | 2014 | 72 | |
| 6 | 2021 | 70 | |
| 7 | 2019 | 62 | |
| 8 | 2018 | 60 | |
| 9 | 2017 | 56 | |
| 10 | 2018 | 53 | |
| 11 | 2014 | 44 | |
| 12 | 2017 | 41 | |
| 13 | 2019 | 41 | |
| 14 | 2008 | 38 | |
| 15 | 2015 | 36 | |
| 16 | 2009 | 29 | |
| 17 | 2018 | 27 | |
| 18 | 2011 | 26 | |
| 19 | 2016 | 26 | |
| 20 | 2021 | 26 |
About Xiang Ma
Xiang Ma is a scholar working on Molecular Biology, Oncology, Organic Chemistry, Radiology, Nuclear Medicine and Imaging and Biomaterials, having authored 60 papers that have together received 1.5k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (9 papers), Radiopharmaceutical Chemistry and Applications (8 papers), Click Chemistry and Applications (7 papers), Synthesis and Characterization of Heterocyclic Compounds (7 papers), RNA Interference and Gene Delivery (7 papers), Peptidase Inhibition and Analysis (6 papers), Synthesis and Biological Evaluation (6 papers) and Drug Transport and Resistance Mechanisms (6 papers). The work is most often cited by research in Biomaterials (447 citations), Molecular Medicine (101 citations), Cancer Research (187 citations), Pharmaceutical Science (74 citations) and Organic Chemistry (292 citations). Xiang Ma has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Guangya Xiang, Tan Yang, Chuanchuan He, Pengxuan Zhao, Wai‐Keung Chui, Yongkang Gai, Yao Lu, Wendian Zhang, Muhammad Sarfraz and Yao Cheng. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Bioconjugate Chemistry, International Journal of Pharmaceutics, International Journal of Nanomedicine and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.